Literature Recap: Commentary
Posted in Papers / Editor's Pick / Commentary / September 16-30, 2022
The elephant in the room: How the underfunding of headache research stunts the field.
Posted on September 28, 2022
Posted in Papers / Commentary / September 16-30, 2022
Editorial: Translational research on neuropathic pain and headache
Posted on September 26, 2022
Posted in Papers / Commentary / September 16-30, 2022
A non-oral gepant for acute treatment of migraine.
Posted on September 16, 2022
Posted in Papers / Commentary / September 1-15, 2022
Editorial: Lifestyle modifications to manage migraine.
Posted on September 15, 2022
Posted in Papers / Commentary / September 1-15, 2022
B1 and/or B2? That is the question.
Posted on September 6, 2022
Posted in Papers / Commentary / September 1-15, 2022
Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy.
Posted on September 5, 2022
Posted in Papers / Editor's Pick / Commentary /
The relationship of childhood adversity and migraine and the value of prospective studies.
Posted on September 1, 2022
Posted in Papers / Commentary / August 16-31, 2022
Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine.
Posted on August 27, 2022
Posted in Papers / Commentary / August 1-15, 2022
Editorial: Calcitonin Gene-Related Peptide: Novel Biology and Treatments
Posted on August 5, 2022